Home / Companies / Zentalis Pharmaceuticals, Inc. / 21 Jun 2024
Zentalis Pharmaceuticals, Inc.: meeting of 21 Jun 2024
Votes reported on Form N-PX, item by item
246 Form N-PX filers reported votes at the Zentalis Pharmaceuticals, Inc. meeting of 21 Jun 2024. Their records fall into 3 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
2 nominees; 46.4% of reported votes for; 67 filers withheld from or voted against at least one nominee.
414 vote records from 110 filers. 44 of the 107 filers that marked the item either way voted against management. 3 filers reported this item without a management mark.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
379 vote records from 246 filers. 182 of the 233 filers that marked the item either way voted against management. 13 filers reported this item without a management mark.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
207 vote records from 110 filers. 1 of the 107 filers that marked the item either way voted against management. 3 filers reported this item without a management mark.
How the largest families voted
| Family | 1. Directors | 2. Say-on-pay | 3. Auditor |
|---|---|---|---|
| Vanguard | For | For | For |
| BlackRock and iShares | For | For | For |
| Fidelity | Abstain or withhold * | Against * | For |
| Dimensional | Abstain or withhold * | Against * | For |
| State Street and SPDR | Abstain or withhold * | Against * | For |
| American Century | Abstain or withhold * | Against * | For |
| Invesco | For | Against * | For |
| Equitable | For | For | For |
| Charles Schwab | For | Against * | For |
| Nuveen and TIAA | Split or no vote | For | For |
| ProShares and ProFunds | Abstain or withhold * | Against * | For |
| John Hancock and Manulife | For | Against * | For |
| Morgan Stanley, Eaton Vance and Calvert | Abstain or withhold * | Against * | For |
| J.P. Morgan | Split or no vote | Against * | For |
| Goldman Sachs | Abstain or withhold * | Against * | For |
| PGIM and Prudential | For | Against * | For |
| Jackson National funds | Abstain or withhold * | Against * | For |
| Northern Trust and FlexShares | Abstain or withhold * | Against * | For |
| SEI | For | Against * | For |
| T. Rowe Price | For | Against * | For |
| Thrivent | Abstain or withhold * | Against * | For |
| Lincoln Financial | Abstain or withhold * | Against * | For |
| Voya | For | Against * | For |
| Nationwide | Abstain or withhold * | Against * | For |
| Victory Capital | Abstain or withhold * | Against * | For |
| Brighthouse Funds | For | Against * | For |
| Guggenheim and Rydex | Abstain or withhold * | Against * | For |
| Columbia Threadneedle | No report | Against * | No report |
| BNY Mellon | No report | Against * | No report |
| Principal | Abstain or withhold * | Against * | For |
| Capital Group and American Funds | For | Against * | For |
| Pacific Life funds | For | For | For |
| Global X | For | Against * | For |
| Transamerica | For | Against * | For |
| Federated Hermes | For | For | For |
| AllianceBernstein | No report | Against * | No report |
| DWS | Abstain or withhold * | Against * | For |
| MassMutual | Split or no vote | Split or no vote | Split or no vote |
| Janus Henderson | No report | Against * | No report |
| Neuberger Berman | No report | Against * | No report |
| Natixis and Loomis Sayles | No report | Against * | No report |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Zentalis Pharmaceuticals, Inc. meeting?
246 Form N-PX filers reported votes at the meeting of 21 Jun 2024. On say-on-pay, 182 of 233 voted against management (78.1%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Zentalis Pharmaceuticals, Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Zentalis Pharmaceuticals, Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Zentalis Pharmaceuticals, Inc. with a meeting date within three days of 21 Jun 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.